全血3基因特征作为利福喷汀基结核预防性治疗的决策辅助工具
研究前瞻性招募187例接受3HP方案(每周利福喷汀联合异烟肼12次)者,其中44例发生全身性药物反应(SDR)、143例未发生。通过全血转录组数据和RT-qPCR筛选基因,构建3基因模型预测SDR风险,在训练和测试队列联合中灵敏度0.972、特异度0.947。
要点
- 3HP方案相关SDR的3基因预测模型灵敏度0.972、特异度0.947。
- 模型在不同亚组中表现良好,可作为个体化安全方案的指导。
- 该模型为药物超敏反应的后续研究提供了潜在转化价值。
核心结论
- 3HP相关SDR的预测模型可作为建立安全个体化方案的指南,以促进LTBI规划的实施。
- 该模型为未来药物超敏反应研究提供了潜在转化价值。
研究设计与样本
- 前瞻性招募187例接受3HP方案者,其中SDR 44例、非SDR 143例。
- 选取预试验队列(8例SDR和12例非SDR)生成全血转录组数据。
- 通过RT-qPCR评估候选基因,并应用可解释机器学习模型(SHAP值)进行SDR风险预测。
- 使用独立队列评估预测模型性能。
主要发现
- 基于预试验队列全血转录组谱和训练队列中2例SDR与3例非SDR样本的RT-qPCR结果,筛选出6个基因。
- 根据SHAP值构建和验证模型,3基因模型在训练队列(28例SDR和104例非SDR)与测试队列(8例SDR和27例非SDR)联合的通用截断值下,灵敏度为0.972、特异度为0.947。
- 模型在不同亚组中均表现良好。
关键数值与推荐
- 3基因模型预测SDR的灵敏度0.972、特异度0.947(训练与测试队列联合,通用截断值)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systemic drug reaction (SDR) is a major safety concern with weekly rifapentine plus isoniazid for 12 doses (3HP) for latent tuberculosis infection (LTBI). Identifying SDR predictors and at-risk participants before treatment can improve cost-effectiveness of the LTBI program. METHODS: We prospectively recruited 187 cases receiving 3HP (44 SDRs and 143 non-SDRs). A pilot cohort (8 SDRs and 12 non-SDRs) was selected for generating whole-blood transcriptomic data. By incorporating the hierarchical system biology model and therapy-biomarker pathway approach, candidate genes were selected and evaluated using reverse-transcription quantitative polymerase chain reaction (RT-qPCR). Then, interpretable machine learning models presenting as SHapley Additive exPlanations (SHAP) values were applied for SDR risk prediction. Finally, an independent cohort was used to evaluate the performance of these predictive models. RESULTS: Based on the whole-blood transcriptomic profile of the pilot cohort and the RT-qPCR results of 2 SDR and 3 non-SDR samples in the training cohort, 6 genes were selected. According to SHAP values for model construction and validation, a 3-gene model for SDR risk prediction achieved a sensitivity and specificity of 0.972 and 0.947, respectively, under a universal cutoff value for the joint of the training (28 SDRs and 104 non-SDRs) and testing (8 SDRs and 27 non-SDRs) cohorts. It also worked well across different subgroups. CONCLUSIONS: The prediction model for 3HP-related SDRs serves as a guide for establishing a safe and personalized regimen to foster the implementation of an LTBI program. Additionally, it provides a potential translational value for future studies on drug-related hypersensitivity.
引用
- Huang HL, Lee JY, Lo YS, et al. Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy. Clin Infect Dis. 2022. PMID: 34989801. doi:10.1093/cid/ciac003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。